[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"content-doc-dcio2df23e8c":3},{"user":4,"document":8,"mainDocument":27,"columnUrl":29,"subscription":30,"footer":42,"text":80},{"isAuthenticated":5,"isAdmin":5,"displayName":6,"avatarUrl":6,"nid":6,"groupLevel":7},false,"",-10,{"id":9,"fullTitle":10,"subTitle":6,"url":11,"columnId":12,"columnName":13,"columnUrl":14,"summary":6,"contentHtml":15,"mainContentHtml":6,"posterUrl":16,"createDate":17,"displayDate":18,"displayDateSlash":19,"pageviews":20,"tags":21,"hidden":5,"isSubContent":5,"replyDocOrTargetId":6,"contentType":23,"videoId":6,"liveVideoUrl":6,"useContentVideo":5,"duration":24,"price":24,"priceText":25,"priceBadgeText":25,"priceBadgeClass":26,"freeForMinGroupLevel":24,"redirectUrl":6,"readyToStream":5},"dcio2df23e8c","美国口服减肥药竞争升级！礼来(LLY)Foundayo抢下三成新患者，诺和诺德(NVO)先发优势收窄","\u002Fdoc\u002Fdcio2df23e8c","col18178739ee","美股资讯","\u002Fcol\u002Fcol18178739ee","\u003Cp>\n\u003C\u002Fp>\u003Cp>\u003Cspan>美股投资网获悉，礼来(LLY)周一表示，其口服减肥药Foundayo已在美国口服肥胖症治疗市场的新增患者中占据超过30%的份额，缩小了丹麦竞争对手诺和诺德(NVO)凭借其Wegovy口服片剂所取得的早期领先优势。\u003C\u002Fspan>\u003C\u002Fp>\n\u003Cp>\u003Cspan>据了解，礼来的口服减肥药Foundayo于4月初上市，比诺和诺德的竞品Wegovy口服片晚了约三个月。\u003C\u002Fspan>\u003C\u002Fp>\n\u003Cp>\u003Cspan>诺和诺德CEO迈克·杜斯达尔(Mike Doustdar)在8月曾表示，尽管面临礼来口服药物Foundayo的竞争，该公司估计Wegovy口服片剂已占据美国口服减肥市场约90%的份额。\u003C\u002Fspan>\u003C\u002Fp>\n\u003Cp>\u003Cspan>投资者正在密切关注口服减肥药的需求，这类药物有望通过吸引不愿使用注射剂的患者来扩大减肥市场，并缓解与注射疗法相关的一些供应挑战。\u003C\u002Fspan>\u003C\u002Fp>\n\u003Cp>\u003Cspan>诺和诺德在1月表示，预计到2030年，口服药物将占GLP-1减肥治疗使用量的三分之一以上。分析师预计，到那一年，仅美国整体的肥胖症治疗市场年规模就将超过1000亿美元。\u003C\u002Fspan>\u003C\u002Fp>\n\u003Cp>\u003Cspan>礼来执行副总裁伊利亚·尤法(Ilya Yuffa)在纽约举行的摩根士丹利医疗健康会议上表示，礼来的注射型GLP-1减肥药物Zepbound在7月推出的美国政府Medicare减肥药试点项目中也受到患者的青睐。\u003C\u002Fspan>\u003C\u002Fp>\n\u003Cp>\u003Cspan>尤法表示，该项目允许符合条件的受益人每月以50美元的自付费用获得减肥药物，参与该项目的患者中有60%至70%是首次接受此类治疗。Medicare面向65岁及以上人群或残障人士，覆盖约6600万人。\u003C\u002Fspan>\u003C\u002Fp>\n\u003Cp>\u003Cspan>在美国以外，礼来在印度和加拿大也面临新的竞争，诺和诺德的重磅减肥和糖尿病治疗药物——Wegovy和Ozempic——的仿制版本在这些市场的价格低至原价的70%。\u003C\u002Fspan>\u003C\u002Fp>\n\u003Cp>\u003Cspan>但尤法表示，这些仿制药的上市只是让市场变得更大了。\u003C\u002Fspan>\u003C\u002Fp>\n\u003Cp>\u003Cspan>他补充道“当市场通过仿制药大幅扩展时，市场份额会下降。但在那些市场中，Mounjaro的整体销量、绝对销量仍在持续增长。”Mounjaro是礼来替尔泊肽(tirzepatide)在美国以外市场用于肥胖症和糖尿病领域的品牌名称。\u003C\u002Fspan>\u003C\u002Fp>\n\u003Cp>\u003Cspan>最专业的美股资讯,推荐美股大数据 \u003Ca href=\"https:\u002F\u002FStockwe.com\u002F\">https:\u002F\u002FStockwe.com\u002F\u003C\u002Fa>\u003C\u002Fspan>\u003C\u002Fp>\n\u003Cp>\u003Cspan>如何识别美股市场异常波动？美国机构主力资金买卖情况，出货和吸筹，使用美股投资网VIP会员，2008年成立于美国硅谷，由前纽约证券交易所分析师Ken创立，联合多位摩根斯坦利分析师，谷歌 Meta工程师利用AI和大数据，配合十多年美股实战经验和业内量化模型，建立了一个股市数据库 \u003Ca href=\"https:\u002F\u002FStockWe.com\u002F\">https:\u002F\u002FStockWe.com\u002F\u003C\u002Fa> 每天处理千万级股票数据：捕捉期权大单，实时主力资金流向、机构持仓变化、川普突发新闻，精准交易信号第一时间发到您手机APP！\u003C\u002Fspan>\u003C\u002Fp>\n\u003Cp>\u003C\u002Fp>","https:\u002F\u002Fwww.tradesmax.com\u002Fimages\u002Fa_Stock\u002FL\u002FLLY\u002FLLY.jpg","2026-09-15T19:21:11","2026.09.15","2026\u002F09\u002F15",57089,[22],"LLY","Article",0,"免费","success",{"id":9,"fullTitle":10,"subTitle":6,"url":11,"columnId":12,"columnName":13,"columnUrl":14,"summary":6,"contentHtml":15,"mainContentHtml":6,"posterUrl":16,"createDate":17,"displayDate":18,"displayDateSlash":19,"pageviews":20,"tags":28,"hidden":5,"isSubContent":5,"replyDocOrTargetId":6,"contentType":23,"videoId":6,"liveVideoUrl":6,"useContentVideo":5,"duration":24,"price":24,"priceText":25,"priceBadgeText":25,"priceBadgeClass":26,"freeForMinGroupLevel":24,"redirectUrl":6,"readyToStream":5},[22],"\u002Fcol\u002Fstocknews",{"visible":5,"marketingHtml":31,"services":32,"recentDocuments":41},"\u003Cfigure class=\"image\">\u003Ca href=\"https:\u002F\u002Fstockwe.com\u002Fdoc\u002Fdcio537efad5\" rel=\"noopener noreferrer\">\u003Cimg src=\"\u002Fimg\u002Fstockwewebfiles\u002Fweb-202408-stk\u002F1586109431mceclip0.jpg\">\u003C\u002Fa>\u003C\u002Ffigure>\u003Cdiv class=\"text-center\">\u003Ch2 class=\"card-title mx-auto\">\u003Cbr>\u003Ca rel=\"noopener noreferrer\" href=\"https:\u002F\u002Fstockwe.com\u002Fdoc\u002Fdcio537efad5\">案例介绍：英伟达深度研究报告\u003C\u002Fa>\u003C\u002Fh2>\u003C\u002Fdiv>",[33,37],{"productId":34,"serviceName":35,"priceText":36},"prod_PPxdDdK87QaiLv","月付","$12.95美元",{"productId":38,"serviceName":39,"priceText":40},"prod_PPxeMs3bix1da5","年付","$149.00美元",[],{"links":43,"images":71,"summaryHtml":76,"aboutTitle":77,"aboutHtml":78,"copyrightHtml":79},[44,47,50,53,56,59,62,65,68],{"label":45,"url":46},"深度报告","\u002Fcol\u002FdepthReport",{"label":48,"url":49},"VIP会员","\u002Fvip",{"label":51,"url":52},"期权推荐","\u002FOption",{"label":54,"url":55},"低价暴涨股","\u002FPenny",{"label":57,"url":58},"AI智能体","\u002FAiAgent",{"label":60,"url":61},"常见问题","https:\u002F\u002Fstockwe.com\u002FFAQ",{"label":63,"url":64},"美股课程","\u002Fcol\u002Fvideos",{"label":66,"url":67},"免责声明","\u002Fdisclaimer",{"label":69,"url":70},"联系我们","\u002FContactUs",[72,73,74,75],"\u002Fimg\u002Fstockwebsiteblob\u002Fweb-202509-stk\u002FUploaderzic2tuwsol2_2025_09_11_18_21_07.gif","\u002Fimg\u002Fstockwebsiteblob\u002Fweb-202509-stk\u002FUploadercakzdvydksw_2025_09_03_09_00_56.png","\u002Fimg\u002Fstockwebsiteblob\u002Fweb-202509-stk\u002FUploadergtjyagwvoyk_2025_09_14_08_32_05.png","\u002Fimg\u002Fstockwebsiteblob\u002Fweb-202509-stk\u002FUploader3u0tt4jhlqh_2025_09_23_22_30_48.png","邮箱: buy@TradesMax.com 美国电话 626-378-3637","公司介绍","\u003Cp class=\"MsoNormal\">美股大数据 \u003Ca href=\"https:\u002F\u002Fstockwe.com\" rel=\"noopener\">StockWe.com\u003C\u002Fa> 是一个美国领先的金融和美股信息大数据提供商，紧盯华尔街金融市场和行情，2008年成立于美国硅谷，创始人是前纽约证券交易所资深分析师Ken，联合多位摩根斯坦利分析师，谷歌 Meta工程师利用AI和大数据，配合十多年美股实战经验和业内量化交易模型，每天处理海量股票数据：挖掘潜力大牛股，捕捉期权异动大单，实时主力资金流向、机构持仓变化、川普突发新闻，美股买卖信号第一时间发到您手机APP。\u003C\u002Fp>","专业美股投资者都在这里",{"loading":81,"search":82,"searchPlaceholder":82,"hotContent":83,"draft":84,"noData":85,"searchNoData":86,"courseContent":87,"more":88,"buyNow":89,"subscribeNow":90,"encoding":91,"paidContent":92},"Loading...","搜索","热门内容","草稿","目前没有任何内容公布","当前检索内容没有数据","课程内容","更多","立即购买后观看","- 立即订阅 -","视频编码中...","付费内容"]